• 75.2k views

Prevention and Treatment of Osteoporosis

The prevention and treatment of osteoporosis involve a multifaceted approach aimed at increasing bone density and strength to reduce the risk of fractures. Prevention includes adequate intake of calcium and vitamin D through diet or supplements, regular weight-bearing and muscle-strengthening exercises, lifestyle modifications such as quitting smoking and limiting alcohol consumption, and fall prevention strategies to reduce fracture risk. For treatment, bisphosphonates are commonly prescribed to slow bone loss, while denosumab, selective estrogen receptor modulators (SERMs), and parathyroid hormone analogs like teriparatide may be used to stimulate bone formation. Additionally, hormone replacement therapy (HRT) can be considered in some postmenopausal women, although its use must be carefully weighed against potential risks. Regular bone density tests are recommended to monitor the effectiveness of treatment and adjust as necessary, emphasizing the importance of a tailored approach based on individual risk factors and overall health.

About the Speaker

Dr. Yamini Dhar Profile Image

Dr. Yamini Dhar

Specialist Obstetrics and Gynecology, Alzahra Hospital

Upcoming CME Events

Leave a Comment

Your email address will not be published.

Author Post

authorimage

Impact

+

Talks

+

webinar

+

no.of registrations

One liner about speaker

Why is speaker relevant?

Dr. Yamini Dhar's Talks on Assimilate

webinar
Dr. Yamini Dhar
  • 0

The prevention and treatment of osteoporosis involve a multifaceted approach aimed at increasing bone density and strength to reduce the risk of fractures. Prevention includes adequate intake of calcium and vitamin D through diet or supplements, regular weight-bearing and muscle-strengthening exercises, lifestyle modifications such as quitting smoking and limiting alcohol consumption, and fall prevention strategies to reduce fracture risk. For treatment, bisphosphonates are commonly prescribed to slow bone loss, while denosumab, selective estrogen receptor modulators (SERMs), and parathyroid hormone analogs like teriparatide may be used to stimulate bone formation. Additionally, hormone replacement therapy (HRT) can be considered in some postmenopausal women, although its use must be carefully weighed against potential risks. Regular bone density tests are recommended to monitor the effectiveness of treatment and adjust as necessary, emphasizing the importance of a tailored approach based on individual risk factors and overall health.

webinar
Dr. Yamini Dhar
  • 0

The prevention and treatment of osteoporosis involve a multifaceted approach aimed at increasing bone density and strength to reduce the risk of fractures. Prevention includes adequate intake of calcium and vitamin D through diet or supplements, regular weight-bearing and muscle-strengthening exercises, lifestyle modifications such as quitting smoking and limiting alcohol consumption, and fall prevention strategies to reduce fracture risk. For treatment, bisphosphonates are commonly prescribed to slow bone loss, while denosumab, selective estrogen receptor modulators (SERMs), and parathyroid hormone analogs like teriparatide may be used to stimulate bone formation. Additionally, hormone replacement therapy (HRT) can be considered in some postmenopausal women, although its use must be carefully weighed against potential risks. Regular bone density tests are recommended to monitor the effectiveness of treatment and adjust as necessary, emphasizing the importance of a tailored approach based on individual risk factors and overall health.

webinar
Dr. Yamini Dhar
  • 0

The prevention and treatment of osteoporosis involve a multifaceted approach aimed at increasing bone density and strength to reduce the risk of fractures. Prevention includes adequate intake of calcium and vitamin D through diet or supplements, regular weight-bearing and muscle-strengthening exercises, lifestyle modifications such as quitting smoking and limiting alcohol consumption, and fall prevention strategies to reduce fracture risk. For treatment, bisphosphonates are commonly prescribed to slow bone loss, while denosumab, selective estrogen receptor modulators (SERMs), and parathyroid hormone analogs like teriparatide may be used to stimulate bone formation. Additionally, hormone replacement therapy (HRT) can be considered in some postmenopausal women, although its use must be carefully weighed against potential risks. Regular bone density tests are recommended to monitor the effectiveness of treatment and adjust as necessary, emphasizing the importance of a tailored approach based on individual risk factors and overall health.